Promising new drug stops spread of melanoma by 90 percent

Scleroderma is a rare and often fatal autoimmune disease that causes the hardening of skin tissue, as well as organs such as the lungs, heart and kidneys. Researchers have discovered that a chemical compound, and potential new drug, reduces the spread of melanoma cells by up to 90 percent.